CRMD vs ERAS

Head-to-Head Stock Analysis & Investment Rating

Last Updated: Aug 01, 2026

CRMD

49.4
AI Score
VS
ERAS Wins

ERAS

50.7
AI Score

Investment Advisor Scores

CRMD

49score
Recommendation
HOLD

ERAS

51score
Recommendation
HOLD

AI Analyst Insights

AI insights temporarily unavailable

Detailed Metrics Comparison

Metric CRMD ERAS Winner
Net Income 163.06M -183.44M CRMD
Operating Income 150.14M -187.91M CRMD
ROE 40.2% -46.6% CRMD
ROA 19.7% -39.8% CRMD
Total Assets 826.14M 461.23M CRMD
Cash 144.84M 47.26M CRMD
Current Ratio 2.11 9.52 ERAS
Free Cash Flow 172.79M -27.42M CRMD

Relative Price Performance (Last 90 Days)

CRMD 1M: -13.7% · 3M: -3.1% ERAS 1M: -3.4% · 3M: +77.9%

Current Technical Phase

CRMD

Neutral
Hold

Mixed signals - no dominant trend phase, RSI 41

RSI (14): 41.4 · Price: $7.55

ERAS

Neutral
Hold

Mixed signals - no dominant trend phase, RSI 49

RSI (14): 48.7 · Price: $17.84

Fundamentals Snapshot

Metric CRMD ERAS
Market Cap
Forward P/E 85.8 -32.3
Trailing P/E 3.5
Revenue (TTM)
Revenue Growth 2.3% 0.0%
Gross Margin 0.9%
Operating Margin 0.5% 0.0%
EPS 2.17 -0.93
Dividend Yield

Frequently Asked Questions

Based on our detailed analysis, ERAS is currently the stronger investment candidate, winning 1 of the key financial metrics based on our comprehensive scoring model.

We analyze revenue and earnings growth rates in the "Growth" section above. Generally, the company with higher year-over-year revenue and EPS growth is fostering better expansion. Check the table above for the specific growth percentages.

Valuation is determined by metrics like the P/E Ratio and PEG Ratio. A lower P/E typically suggests a stock is cheaper relative to its earnings. Refer to the "Valuation" section in our comparison table to see which stock currently trades at a more attractive multiple.